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Respiratory cytochrome c has been found to be phosphorylated at
tyrosine 97 in the postischemic brain upon neuroprotective insulin
treatment, but how such posttranslational modification affects mi-
tochondrial metabolism is unclear. Here, we report the structural
features and functional behavior of a phosphomimetic cytochrome
c mutant, which was generated by site-specific incorporation at
position 97 of p-carboxymethyl-L-phenylalanine using the evolved
tRNA synthetase method. We found that the point mutation does
not alter the overall folding and heme environment of cytochrome
c, but significantly affects the entire oxidative phosphorylation
process. In fact, the electron donation rate of the mutant heme
protein to cytochrome c oxidase, or complex IV, within respiratory
supercomplexes was higher than that of the wild-type species, in
agreement with the observed decrease in reactive oxygen species
production. Direct contact of cytochrome c with the respiratory
supercomplex factor HIGD1A (hypoxia-inducible domain family
member 1A) is reported here, with the mutant heme protein
exhibiting a lower affinity than the wild-type species. Interestingly,
phosphomimetic cytochrome c also exhibited a lower caspase-3 ac-
tivation activity. Altogether, these findings yield a better under-
standing of the molecular basis for mitochondrial metabolism in
acute diseases, such as brain ischemia, and thus could allow the
use of phosphomimetic cytochrome c as a neuroprotector with
therapeutic applications.
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Cell redox signaling is fine-tuned by protein phosphorylation,a well-known posttranslational modification in turn modu-
lated by the antagonistic effects of kinases and phosphatases (1, 2).
Such an interplay is specifically relevant in mitochondrial metab-
olism, which is the main source of reactive oxygen species/reactive
nitrogen species (ROS/RNS) in the cell (3). Tyrosine kinases, in
particular, are key signaling mediators and their perturbations
underlie many human pathologies, namely cancer and neurode-
generative diseases (4, 5). One of the main proteins that control
redox signaling in mitochondrial oxidative phosphorylation
(OxPhos) is cytochrome c (Cc), the functions of which are reg-
ulated by phosphorylation of several residues (6–10).
Cc plays a double role in the cellular metabolism. Under ho-
meostasis, Cc is located in the mitochondrial intermembrane
space, where it acts as an electron carrier between complex III
(CIII) and complex IV (CIV) in the electron transfer chain
(ETC). These two respiratory complexes can be either in-
dependent or associated with each other and with complex I
(CI), thus forming mitochondrial supercomplexes—the so-called
respirasome—the assembly of which is strictly dependent on
metabolic needs (11). Respiratory supercomplexes provide
higher efficiency to the electron transport during OxPhos,
thereby minimizing the generation of ROS (12). Respiratory
supercomplex factors (Rcfs) are protein modulators that stabi-
lize the membrane-embedded CIII and CIV within respiratory
supercomplexes. These factors have been found in both yeasts and
mammals. In yeasts, they are called respiratory supercomplex
factor 1 (Rcf1, formerly Aim31) and respiratory supercomplex
factor 2 (Rcf2, formerly Aim38), both being members of the
conserved hypoxia-induced gene 1 (Hig1) protein family (13, 14).
Rcf1 has two human orthologs, namely the HIG hypoxia-inducible
domain family members 1A and 2A (HIGD1A and HIGD2A,
respectively) (15). Rcf2, in contrast, is yeast-specific and neces-
sary for oligomerization of a subclass of Cc oxidase (CcO) into
supercomplexes.
Under nitro-oxidative stress conditions, Cc acts as a pro-
grammed cell death (PCD) inducer (16). During early apoptosis, a
Cc population—tightly bound to the mitochondrial membrane—
triggers peroxidation of phospholipids and, in particular, of car-
diolipin (CL). CL-adducted Cc undergoes a profound tertiary
conformational rearrangement that opens an entry channel for
H2O2 molecules, which explains how Cc enhances its peroxidase
activity (17, 18). It has been proposed that Cc-CL conjugates are
sufficient for formation of mitochondrial pores, allowing the re-
lease of the hemeprotein into the cytosol during apoptosis (19).
Extramitochondrial Cc binds to the apoptotic protease-
activating factor 1 (Apaf1), thereby eliciting the apoptosome
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platform assembly and activating the caspase cascade (20, 21).
Recent data indicate that the programmed cell death network
involving Cc is complex, and that Cc targets several proteins that
are functionally equivalent in humans and plants (22–24). In
both type of cells, for example, Cc reaches the cell nucleus upon
DNA damage and sequesters human SET/TAF1β and plant
NRP1 histone chaperones that remodel chromatin (25–27).
In addition to regulating the functions described above,
phosphorylated Cc species have been associated with several
human pathologies. In fact, it has been proposed that Tyr97 is
target of phosphorylation during the insulin-induced neuro-
protection response following a brain ischemic injury (28). A
possible mechanism could be that Tyr97 phosphorylation of Cc
would alter the electron shuttling to CcO (7). Notably, electron
transfer from wild-type (WT) Cc to CcO is positively regulated
by the HIGD1A membrane protein (29).
Research on tyrosine phosphorylation of Cc has normally
resorted to using Tyr-to-Glu mutations (30, 31). This overcomes
the difficulties of obtaining enough phosphorylated Cc for
biophysical and functional studies when the specific Cc-phos-
phorylating kinase is unknown (32). However, the Tyr-to-Glu
substitution leads to a substantial decrease in the residue vol-
ume and the loss of an aromatic ring. Therefore, we used the
evolved tRNA synthetase technique to introduce the non-
canonical amino acid p-carboxymethyl-L-phenylalanine (pCMF)
at position 97, as previously reported for Tyr48 (33). This non-
canonical amino acid is actually used to synthesize stable analogs
of a wide array of phosphoproteins, the kinases of which are
unknown or the yields of which from tissues are low. In addition,
pCMF provides a dependable analog of phosphorylated tyrosine
that can be used to study signal transduction pathways. In this
work, the resulting Y97pCMF Cc mutant maintained its overall
folding and heme environment. We found that such a post-
translational modification of Cc affected the OxPhos process
since it enhanced the electron donation rate to CcO in mito-
chondria isolated from yeasts grown in respiratory metabolism.
In addition, we observed a decrease in the production of ROS.
Thus, the CcO-driven oxidation rate of Cc is controlled by
Table 1. Midpoint melting temperature (Tm) (°C) of WT and
Y97pCMF Cc
Cc species
Far-UV
CD,
220 nm
Visible CD,
419 nm
Fluorescence,
270 nm
WT 88.6 ± 1.9 43.9 ± 2.0 (Tm1) 86.3 ± 1.4
85.1 ± 2.3 (Tm2)
Y97pCMF 82.2 ± 0.3 76.6 ± 4.9 82.6 ± 1.6
Fig. 1. Modulation of CcO activity by the HIGD1A protein and interaction of the latter with Cc. (A) Bovine CcO activity with added WT (blue) or Y97pCMF
(red) Cc as electron donor in the presence of the chimera MBP-HIGD1A at varying concentrations. The 1:0 bars represent the CcO activity without MBP-
HIGD1A. Experimental data were normalized to the Cc:HIGD1A ratio of 1:0 for WT Cc species. a.u.: arbitrary units. (B) Immunoprecipitation of transfected
HIGD1A-mCherry with Cc in Heltog cells. (Left) Western blot shows the detection of the HIGD1A-mCherry band in the lysates, along with Cc-IP of lysates
followed by probing with the HIGD1A antibody (arrow). Mouse IgG (IgG) was used as control. (Right) Detection of Cc band in lysates and Cc-
immunoprecipitated lysates are also shown (arrow). Asterisks and hashtags are heavy and light chains of IgG, respectively. The black circle stands for un-
specific bands of anti-Cc antibody, as reported by the manufacturer. (C) Western blots against cytosolic (tubulin), mitochondrial (Hsp60), and nuclear (H3)
markers. (D) Subcellular localization of HIGD1A and Cc proteins by confocal microscopy. Heltog cells were transfected to express the chimera HIGD1A-mCherry
(red; first column of Upper and Middle rows). The chimera Cc-GFP is stably expressed in the Heltog cell line (green; second columns). Nuclei were stained in blue
with Hoechst (third columns) and mitochondria with MitoTracker Red CMXRos (red, first panel of Lower row). Colocalization between green Cc-GFP and red
HIGD1A-mCherry in mitochondria, along with blue nuclear staining, is shown in the merge images (last columns of Upper and Middle rows). (Scale bars: 10 μm.)
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phosphorylation to maintain low levels of apoptotic-inducing
ROS. Furthermore, Y97pCMF Cc was an inefficient caspase
activator. Altogether, these findings can shed light on the func-
tion of phosphorylated Cc in insulin-stimulated postischemic
neuroprotection.
Results and Discussion
Substitution of Tyr97 with pCMF Allows for Study of Cc Phosphorylation,
Preserving Its Physicochemical Properties. To accurately study the
phosphorylation of Cc at Tyr97, this residue was substituted
with the noncanonical amino acid pCMF, which is an analog of
phosphotyrosine residue. To do that, we used the evolved
tRNA synthetase method as previously reported (SI Appendix,
Fig. S1). As described above, this substitution simulates the
charge and the volume of a phosphotyrosine residue better than
a glutamate substitution (33).
To confirm that the noncanonical amino acid pCMF was
successfully introduced at position 97 of the heme protein, the
Y97pCMF Cc mutant was purified to homogeneity, and its mo-
lecular mass was compared with that of WT Cc by MALDI-TOF
(SI Appendix, Fig. S2 A and B). The phosphomimetic mu-
tant presented an increase of 41 Da in its molecular mass in
comparison with that of WT Cc, which is consistent with the
expected substitution (SI Appendix, Fig. S2A). To check whether
the amino acid replacement affected the secondary structure and
heme environment of Cc, circular dichroism (CD) spectroscopy
measurements in the far-UV and visible region were carried out,
respectively. Those data demonstrated that Y97pCMF Cc exhibi-
ted an overall secondary structure and heme properties similar to
those observed for WT Cc (SI Appendix, Fig. S2 C and D).
Following with the biophysical analysis of the Y97pCMF
mutant, the alkaline transition phenomenon was also analyzed.
This phenomenon has been related to a change in the Cc cell
location, which is essential for its role in PCD (34). Such tran-
sition affects the oxidized form of Cc and involves the re-
placement of Met80—the sixth ligand of the heme group—by
Lys72, Lys73, or Lys79 as an axial ligand at high pH values (35).
To analyze the Fe-Met80(Sδ) bond changes induced by pH, we
therefore monitored the charge-transfer band at 699 nm, which
disappears concomitantly with the alkaline transition (SI Ap-
pendix, Fig. S3A) (36). The quantitative analysis yields a differ-
ence of ∼0.8 in the pKa values for this alkaline transition in
the WT and Y97pCMF Cc species (pKa-WT = 8.9 ± 0.4 and
pKa-Y97pCMF = 8.1 ± 0.2; SI Appendix, Fig. S3 B–D).
On the other hand, given that most mutations in Tyr97 per-
formed to date alter the thermal stability of Cc, we explored that
possibility in Y97pCMF Cc (31, 37). In terms of secondary and
overall structure, data from far-UV CD and fluorescence, re-
spectively, showed that the midpoint melting temperature (Tm)
of Y97pCMF was slightly lower than that calculated for WT Cc
(Table 1). Notably, in contrast to the data recorded for the heme
group environment of WT species, the visible CD data of
Y97pCMF Cc fit well into a two-state model (Table 1). Such
findings could indicate a slight destabilization in the N-
terminal α-helix pack, which constitutes an early event in Cc
folding (38–41).
Altogether, the biophysical comparison of WT and Y97pCMF
Cc species indicates that the substitution of Tyr97 with non-
canonical pCMF is a good approach to studying the conse-
quences of Cc phosphorylation without significantly altering the
physicochemical and structural properties.
CcO Activity Is Modulated by Y97pCMF Cc and Respiratory Supercomplex
Factors. Given that phosphorylation of Cc has been described as a
phenomenon that modulates the functions of this metalloprotein,
we explored the behavior of Y97pCMF Cc as an electron donor.
The in vitro ability of Y97pCMF Cc to reduce CcO was measured
in the absence or presence of HIGD1A, which acts as a positive
modulator of CcO (29). In the absence of a modulator, the CcO
activities were slightly higher with the Y97pCMF mutant compared
with the WT Cc (Fig. 1A). Then we wondered whether those slight
changes were due to a change in the molecular recognition mode
between both Cc species and CcO. Thus, we analyzed the in-
teraction between CcO and WT or phosphomimetic Y97pCMF Cc
by isothermal titration calorimetry (ITC) (Fig. 2A and B). Both
isotherms were fitted to a model with two independent binding sites,
as previously described for the cross-complex between human WT
Cc and bovine CcO (42). Notably, the KD values showed that
Y97pCMF Cc had a higher affinity for CcO than did the WT
species. These results would explain the higher CcO activity shown
by the phosphomimetic mutant.
Recently, it has been described that the HIGD1A-dependent
increase in CcO activity was higher with a Cc phosphomimetic
mutant at position 48 (9). For this reason, we tested the effect of the
HIGD1A in CcO activity through WT and Y97pCMF Cc. To avoid
the solubility problem of the membrane protein HIGD1A, we used
a chimera with a maltose binding protein (MBP) tag in its N terminus
(MBP-HIGD1A) (SI Appendix, Fig. S4). Notably, CcO activity
significantly increased upon addition of MBP-HIGD1A through
Y97pCMF Cc (Fig. 1A). To discard a possible contribution from
Fig. 2. ITC assays of CcO and HIGD1A with WT and Y97pCMF Cc. (A and B)
Thermograms (Upper) and binding isotherms (Lower) of WT Cc/CcO (A) and
Y97pCMF Cc/CcO (B) complexes in their reduced states. Experimental data
were fitted to a 2:1 model with the same KD values. (C and D) Thermograms
(Upper) and binding isotherms (Lower) of WT Cc/MBP-HIGD1A (C) and
Y97pCMF Cc/MBP-HIGD1A (D) complexes at reduced states. Data were fitted
to a model with a 1:1 stoichiometry.
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the MBP tag in CcO activity, assays were also performed with
MBP protein in the presence of both Cc species. As shown in SI
Appendix, Fig. S5A, MBP did not alter CcO activity.
Taking into account the differences observed in Fig. 1A, we
would expect an eventual interaction between Cc and HIGD1A.
To explore this further, we examined the interaction between
MBP-HIGD1A and WT or Y97pCMF Cc by ITC (Fig. 2C and
D). These measurements revealed that both Cc species interacted
with MBP-HIGD1A with a stoichiometry of 1:1, yielding dissoci-
ation constant (KD) values within the micromolar range. To
demonstrate that the interaction with the chimera was uniquely
due to the HIGD1A module, we performed an ITC assay between
WT Cc and the MBP protein (SI Appendix, Fig. S5B). These data
revealed the absence of any interaction between both proteins. In
addition, dilution ITC experiments showed that the observed
changes in heat rate are rather due to the interaction between the
Cc species and MBP-HIGD1A (SI Appendix, Fig. S6 A and B).
The redox state of Cc did not affect its interaction with HIGD1A
(SI Appendix, Fig. S6C). Since the N-terminal domain of HIGD1A—
hereafter, HIGD1A1–26—has been reported to retain Cc in the in-
termembrane mitochondrial space (IMS) and to decrease caspase
activation (43), a set of ITC titrations were run. Data resulting from
such titrations evinced that both Cc species interacted with
HIGD1A1–26 with similar stoichiometry values, although Y97pCMF
Cc showed less affinity than WT Cc (SI Appendix, Fig. S7). Thus, the
lesser affinity of Y97pCMF Cc toward HIGD1A1–26 or MBP-
HIGD1A may point out a higher interaction turnover of the
phosphomimetic mutant in comparison with the WT species,
thus facilitating CcO reduction (Fig. 1A).
To test the interaction between HIGD1A and Cc in cells,
coimmunoprecipitation (Co-IP) assays were performed in Hel-
tog cells—HeLa cells constitutively expressing green fluorescent
protein (GFP)-tagged Cc—transfected with HIGD1A-mCherry
vector. Immunoblotting data against HIGD1A corroborated the
interaction between Cc and HIGD1A (Fig. 1B). The total lysate
used in the Co-IP assays contained cytosolic and mitochondrial
fractions, as shown by the detection of tubulin and Hsp60, re-
spectively (Fig. 1C). Furthermore, we checked that both Cc
and HIGD1A were in the same cellular compartment by con-
focal analysis of Heltog cells upon transfection with HIGD1A-
mCherry vector, which codes for red fluorescence-tagged
proteins. The pictures showed that Cc-GFP (green fluores-
cence) colocalized with HIGD1A-mCherry (red fluorescence)
under homeostatic conditions (Fig. 1D, Upper and Middle). The
mitochondrial localization of Cc-GFP was confirmed by code-
tection with the MitoTracker (Fig. 1D, Lower). Altogether, these
findings revealed contacts between HIGD1A and Cc species.
Based on these results, the HIGD1A- and Cc phosphorylation-
mediated regulations of CcO activity were tested in a cellular context
using isolated mitochondria from yeast cells grown on a respiratory
media. Under such growth conditions, Rcf1—a yeast ortholog of
human HIGD1A—and Rcf2 stabilized the CIII–CIV interaction,
favoring the formation of the supercomplexes (13, 14, 44). To ana-
lyze the effect of supercomplex formation, we used mitochondria
obtained from WT and Rcf1/Rcf2-deficient yeast strains (Mitwt and
MitΔΔRcf1/2, respectively). The supercomplex formation was im-
paired in MitΔΔRcf1/2 due to the absence of Rcf1 and Rcf2 proteins
(SI Appendix, Figs. S5C and S8). In fact, CcO activity assays using
MitΔΔRcf1/2 revealed an electron flow significantly lower in com-
parison with those observed using MitWT, regardless whether WT or
Y97pCMF Cc was added (Fig. 3A). In addition, a single deletion of
either Rcf1 or Rcf2 partially affected the CcO activity levels, in-
dicating a cooperative effect when the two membrane proteins Rcf1
and Rcf2 were present (SI Appendix, Fig. S5C). Notably, the
Y97pCMF Cc mutant exhibited higher CcO activity than WT Cc,
both in WT (MitWT) and in mutant mitochondria (MitΔRcf1,
MitΔRcf2, and MitΔΔRCf1/2) (Fig. 3A and SI Appendix, Fig. S5C). This
finding indicates that the Rcf-mediated ETC flow is more efficient
when Y97pCMF Cc participates (Fig. 3A). This suggests a double
regulation mechanism through Cc phosphorylation and super-
complex formation to make an accurate cellular response against
hypoxia or other respiratory stresses and needs.
Y97pCMF Cc Impairs Mitochondrial Supercomplex-Mediated ROS
Production. Changes in the ETC flow can affect the hyperpo-
larization of mitochondrial inner membrane and ROS produc-
tion (45). For this reason, we investigated if the accelerated
CcO-driven oxidation rate of phosphorylated Cc could alter
mitochondrial ROS production both in the absence and in the
presence of respiratory supercomplexes. ROS production in
mitochondria from Saccharomyces cerevisiae occurs mainly in CIII
as its mitochondria are deficient in CI (46, 47). Significant
contribution of complex II (CII) to ROS generation has recently
been described in mammalian mitochondria (48–50). In S. cerevisiae,
however, contribution of CII to ROS generation occurs only when
specific mutations are present near the proximal quinone-binding
Fig. 3. Effect of the respiratory factors on CcO activity and ROS production in isolated mitochondria. (A) CcO activity was measured in isolated mitochondria
with added WT Cc (blue bars) or Y97pCMF Cc (red bars). Data were normalized with respect to the activity with WT Cc in mitochondria isolated from ΔΔRcf1/2
yeast strains. Data represent the mean ± SD of three independent experiments. a.u.: arbitrary units. (B) H2O2 production in isolated MitΔΔRcf1/2 and MitWT. ROS
generation was triggered by addition of succinate. Bar color code is the same as in A. (C) Molecular model of OxPhos and ROS production by respirasome
when Cc is phosphorylated. The CcO-driven oxidation rate of Cc is facilitated by Tyr-97 phosphorylation and supercomplex formation to maintain low levels of
apoptotic-inducing ROS. Blue, CI; green, dimeric CIII; and magenta, CIV. Cc molecules at the proximal sites of one monomer of CIII or CIV are in red, whereas
those at the distal sites are in yellow. HIGD1A, colored in dark blue, makes contacts with CIV and the molecule of Cc located at its proximal site. The black
arrow indicates the channeling of Cc molecules between CIII and CIV. IMM, inner mitochondrial membrane; IMS, intermembrane mitochondrial space; MM,
mitochondrial matrix.
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site (QP) of CII (51). Since our study was focused on Cc-mediated
ROS production, with Cc acting as an electron donor between CIII
and CIV, no ETC inhibitors were used. Therefore, succinate was
added as electron donor to both types of mitochondria, in the
presence of either WT or Y97pCMF Cc, to trigger the ETC through
CII. Upon addition of succinate, ETC-dependent H2O2 production
significantly increased, especially in MitΔΔRcf1/2 where the formation
of supercomplexes is impaired (Fig. 3B and SI Appendix, Fig. S9).
Remarkably, Y97pCMF Cc made ROS production decrease in
MitΔΔRcf1/2 and, more pronouncedly, in MitWT where supercomplexes
are formed (Fig. 3B). These findings suggest that the CcO-driven
oxidation rate of Cc is tightly regulated by Cc phosphorylation and
supercomplex formation to keep apoptotic-inducing mitochondrial
ROS at a low level.
Thus, we propose a respirasome OxPhos model based on the
recently described extra distal Cc-binding sites in CIII and CIV,
thus providing a path for diffusion of Cc molecules (Fig. 3C) (42,
52). This way of communicating between complexes through Tyr97-
phosphorylated Cc could accelerate the electron transfer flow, which,
in turn, would avoid ROS-mediated cellular damage to guarantee
neuronal survival during ischemia reperfusion in the brain (28, 45).
ROS Scavenger Activity and Cardiolipin Binding of Cc Remains
Unaltered upon Phosphorylation. We wondered whether the low
levels of ROS displayed by the presence of Y97pCMF Cc might
be caused by an exacerbated peroxidase activity of the
heme protein. We thus measured such enzymatic activity in WT
and mutant Cc, either free or bound to lipid vesicles containing
CL at a 4:1 ratio [1,2-dioleoyl-sn-glycero-3-phosphocholine:1,1′2,2′-
tetraoleoylcardiolipin (DOPC:TOCL)]. No differences in peroxidase
activity were observed between Y97pCMF and WT Cc species, both
when free or bound to liposomes. It should be noted that the use of
liposomes rose the peroxidase activity considerably, although in the
same way for WT and phosphomimetic Cc (Fig. 4A). This finding
corroborates that the drop in ROS production upon mitochondrial
supercomplex assembly is due to a more efficient CcO-driven oxida-
tion rate by Y97pCMF than by WT Cc.
In addition, the onset of PCD is triggered by the ability of the
hemeprotein to leave the mitochondria after binding to CL (53).
Therefore, a plausible hypothesis is that the decrease in neuronal
ischemic death may be due to a less efficient release of phos-
phorylated Cc to the cytosol, concomitantly with its role as a
PCD inducer. Hence, we examined the binding of Cc species to
liposomes containing CL (DOPC:TOCL) (4:1) or not (DOPC)
by electrophoretic mobility shift assays (EMSA) in native aga-
rose gels (SI Appendix, Fig. S10). The electrophoretic mobility of
Y97pCMF and WT Cc species shifted in the same manner upon
DOPC:TOCL liposome additions, unveiling that both Cc species
were able to bind to CL (SI Appendix, Fig. S10). Likewise, EMSA
data showed that none of the Cc species had altered the elec-
trophoretic mobility with DOPC liposomes, corroborating that
the two Cc species specifically interact with CL and not with
other lipids of the inner mitochondrial membrane. To sum up,
these data showed that there is no evidence that phosphorylated
Cc at Tyr97 is preferably retained in the mitochondria.
Y97pCMF Cc Is an Inefficient Caspase Activator. In the context of
ischemic brain damage, inhibition of both Cc–Apaf1 interaction
and caspase-3 cleavage constitutes a potent neuroprotective
strategy (54, 55). The binding assays involving Cc, HIGD1A,
and CL suggested that both WT and Y97pCMF Cc species did
seem to be equally retained in mitochondria. Therefore, the
neuroprotective role of phosphorylated Cc cannot be fully
explained by a specific sequestration of Y97pCMF Cc in the
IMS. Thus, we explored whether phosphorylation at Tyr97
modulated Cc ability to trigger the caspase cascade in the cy-
tosol, where the hemeprotein interacts with Apaf1 to assemble
the so-called apoptosome.
We analyzed the caspase-3 activation driven by WT and
Y97pCMF Cc, using cytoplasmic extracts of human embryonic
kidney 293 cells that lack Cc (Fig. 4B). The Y97pCMF Cc-mediated
caspase-3 activity decreased by about 26% with respect to that
mediated by WT Cc (Fig. 4B). These findings agree with our
previous results on Y97E and Y97F Ccmutants, as well as with the
nitrated mono-Tyr97 Cc, which have a caspase activation slightly
lower than that of the WT species (31, 56). Interestingly, none of
these Cc species disrupted the Cc/Apaf1 complex assembly, and
this is also expected for the Y97pCMF form. However, the for-
mation of a nonfunctional apoptosome upon posttranslational
modifications of Cc cannot be excluded (31, 56, 57).
Altogether, our data suggest that both low oxidative stress in
mitochondria and less activation of the caspase cascade in cy-
toplasm explain neuronal survival under ischemia damage in
cells containing Tyr97-phosphorylated Cc.
Materials and Methods
Expression of genes in Escherichia coli and purification of Cc and HIGD1A
protein constructs followed standard procedures. All experimental condi-
tions are further available in SI Appendix, including strains, culture
Fig. 4. Peroxidase and caspase activities of Y97pCMF Cc. (A) Peroxidase ac-
tivity of WT Cc (blue) and Y97pCMF Cc (red) either free (empty bars) or in the
presence of liposomes containing DOPC:TOCL (4:1) (filled bars). Data represent
the mean ± SD of three independent experiments and are normalized to the
peroxidase activity of free WT Cc. (B) Caspase-3 activity upon addition of ex-
ogenous WT (blue) or Y97pCMF (red) Cc. Caspase auto-activation, in the ab-
sence of added Cc, was also tested (control bar). Data represent the mean ± SD
of three independent experiments and are normalized with respect to the
activity determined with WT Cc. (Inset) Western blots confirmed the lack of
endogenous Cc in the cytoplasmic cell extracts by immunoblotting with anti-
tubulin (cytosolic marker) and anti-Cc antibodies. Lane 1, cytoplasmic cell ex-
tracts; lane 2, purified Cc; and lane 3, BSA as a negative control.
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conditions, cell transfection experiments, cell-extract fraction analyses,
thermal analyses, and enzymatic activity assays. All biological samples
were obtained from bacteria, yeast, or human cell extracts in full com-
pliance with University of Seville Ethical Committee bylaws.
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